127 related articles for article (PubMed ID: 24284398)
1. Oxidative stress/angiotensinogen/renin-angiotensin system axis in patients with diabetic nephropathy.
Kamiyama M; Urushihara M; Morikawa T; Konishi Y; Imanishi M; Nishiyama A; Kobori H
Int J Mol Sci; 2013 Nov; 14(11):23045-62. PubMed ID: 24284398
[TBL] [Abstract][Full Text] [Related]
2. Activated intrarenal reactive oxygen species and renin angiotensin system in IgA nephropathy.
Ohashi N; Urushihara M; Kobori H
Minerva Urol Nefrol; 2009 Mar; 61(1):55-66. PubMed ID: 19417726
[TBL] [Abstract][Full Text] [Related]
3. Angiotensinogen (AGT) gene missense polymorphisms (rs699 and rs4762) and diabetic nephropathy in Caucasians with type 2 diabetes mellitus.
Makuc J; Šeruga M; Završnik M; Cilenšek I; Petrovič D
Bosn J Basic Med Sci; 2017 Aug; 17(3):262-267. PubMed ID: 28488548
[TBL] [Abstract][Full Text] [Related]
4. Cell autonomous angiotensin II signaling controls the pleiotropic functions of oncogenic K-Ras.
Volonte D; Sedorovitz M; Cespedes VE; Beecher ML; Galbiati F
J Biol Chem; 2021; 296():100242. PubMed ID: 33380422
[TBL] [Abstract][Full Text] [Related]
5. Urinary angiotensinogen as a potential biomarker of diabetic nephropathy.
Satirapoj B; Siritaweesuk N; Supasyndh O
Clin Kidney J; 2014 Aug; 7(4):354-60. PubMed ID: 25852909
[TBL] [Abstract][Full Text] [Related]
6. Angiotensinogen as a Therapeutic Target for Cardiovascular and Metabolic Diseases.
Daugherty A; Sawada H; Sheppard MB; Lu HS
Arterioscler Thromb Vasc Biol; 2024 May; 44(5):1021-1030. PubMed ID: 38572647
[TBL] [Abstract][Full Text] [Related]
7. Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Increases Antioxidative Capacity and Improves Renal Function in Diabetic Rats.
Yaribeygi H; Hemmati MA; Nasimi F; Maleki M; Jamialahmadi T; Reiner I; Reiner Ž; Sahebkar A
J Clin Med; 2023 Jun; 12(11):. PubMed ID: 37298010
[TBL] [Abstract][Full Text] [Related]
8. Network pharmacology study of Yishen capsules in the treatment of diabetic nephropathy.
Fang J; Wang C; Zheng J; Liu Y
PLoS One; 2022; 17(9):e0273498. PubMed ID: 36094934
[TBL] [Abstract][Full Text] [Related]
9. Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System.
Puglisi S; Rossini A; Poli R; Dughera F; Pia A; Terzolo M; Reimondo G
Front Endocrinol (Lausanne); 2021; 12():738848. PubMed ID: 34745006
[TBL] [Abstract][Full Text] [Related]
10. Tetrahydrocurcumin Ameliorates Kidney Injury and High Systolic Blood Pressure in High-Fat Diet-Induced Type 2 Diabetic Mice.
Sangartit W; Ha KB; Lee ES; Kim HM; Kukongviriyapan U; Lee EY; Chung CH
Endocrinol Metab (Seoul); 2021 Aug; 36(4):810-822. PubMed ID: 34474516
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Renin-Angiotensin-Aldosterone System to Prevent Hypertension and Kidney Disease of Developmental Origins.
Hsu CN; Tain YL
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669059
[TBL] [Abstract][Full Text] [Related]
12. Cyst Reduction by Melatonin in a Novel
Millet-Boureima C; Rozencwaig R; Polyak F; Gamberi C
Molecules; 2020 Nov; 25(22):. PubMed ID: 33238462
[TBL] [Abstract][Full Text] [Related]
13. Sweet dreams: therapeutic insights, targeting imaging and physiologic evidence linking sleep, melatonin and diabetic nephropathy.
Afsar B; Elsurer Afsar R; Sag AA; Kanbay A; Korkmaz H; Cipolla-Neto J; Covic A; Ortiz A; Kanbay M
Clin Kidney J; 2020 Aug; 13(4):522-530. PubMed ID: 32905249
[TBL] [Abstract][Full Text] [Related]
14. Alteration and association between serum ACE2/ angiotensin(1-7)/Mas axis and oxidative stress in chronic kidney disease: A pilot study.
Shi C; Lu K; Xia H; Zhang P; Zhang B
Medicine (Baltimore); 2020 Jul; 99(31):e21492. PubMed ID: 32756181
[TBL] [Abstract][Full Text] [Related]
15. Integrated Datasets of Proteomic and Metabolomic Biomarkers to Predict Its Impacts on Comorbidities of Type 2 Diabetes Mellitus.
Cheema AK; Kaur P; Fadel A; Younes N; Zirie M; Rizk NM
Diabetes Metab Syndr Obes; 2020; 13():2409-2431. PubMed ID: 32753925
[TBL] [Abstract][Full Text] [Related]
16. Diabetes-induced upregulation of kallistatin levels exacerbates diabetic nephropathy via RAS activation.
Yang Y; He X; Cheng R; Chen Q; Shan C; Chen L; Ma JX
FASEB J; 2020 Jun; 34(6):8428-8441. PubMed ID: 32352602
[TBL] [Abstract][Full Text] [Related]
17. Identification of core genes and pathways in type 2 diabetes mellitus by bioinformatics analysis.
Ding L; Fan L; Xu X; Fu J; Xue Y
Mol Med Rep; 2019 Sep; 20(3):2597-2608. PubMed ID: 31524257
[TBL] [Abstract][Full Text] [Related]
18. High glucose level and angiotensin II type 1 receptor stimulation synergistically amplify oxidative stress in renal mesangial cells.
Akaishi T; Abe M; Okuda H; Ishizawa K; Abe T; Ishii T; Ito S
Sci Rep; 2019 Mar; 9(1):5214. PubMed ID: 30914692
[TBL] [Abstract][Full Text] [Related]
19. A Network Pharmacology Approach to Uncover the Mechanisms of Shen-Qi-Di-Huang Decoction against Diabetic Nephropathy.
Di S; Han L; Wang Q; Liu X; Yang Y; Li F; Zhao L; Tong X
Evid Based Complement Alternat Med; 2018; 2018():7043402. PubMed ID: 30519269
[TBL] [Abstract][Full Text] [Related]
20. The relationships between markers of tubular injury and intrarenal haemodynamic function in adults with and without type 1 diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.
Bjornstad P; Singh SK; Snell-Bergeon JK; Lovshin JA; Lytvyn Y; Lovblom LE; Rewers MJ; Boulet G; Lai V; Tse J; Cham L; Orszag A; Weisman A; Keenan HA; Brent MH; Paul N; Bril V; Perkins BA; Cherney DZI
Diabetes Obes Metab; 2019 Mar; 21(3):575-583. PubMed ID: 30311395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
